Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences

Details for Australian Patent Application No. 2003219837 (hide)

Owner ViroNovative BV MedImmune, LLC

Inventors Tang, Roderick; Osterhaus, Albertus Dominicus Marcellinus Erasmus; Fouchier, Ronaldus Adrianus Maria; Haller, Aurelia; Van Den Hoogen, Bernadetta Gerarda

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003219837

PCT Number PCT/US03/05271

PCT Pub. Number WO2003/072719

Priority 60/358,934 21.02.02 US

Filing date 21 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 29 October 2009

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C07K 14/115 (2006.01) Peptides having more than 20 amino acids

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/358,934 21.02.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219837

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219837

2 October 2008 Assignment before Grant

  ViroNovative BV; Medimmune Vaccines, Inc. The application has been assigned to ViroNovative BV; MedImmune, LLC

9 October 2008 Alteration of Name

  The name of the applicant has been altered to ViroNovative BV; MedImmune, LLC

29 October 2009 Application Accepted

  Published as AU-B-2003219837

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219838-Compositions and method for regulation of calcium-dependent signalling in brain

2003219836-PROCESS FOR SORTING MOTILE PARTICLES FROM LESSER-MOTILE PARTICLES AND APPARATUS SUITABLE THEREFOR